Roche Covid-19 and Influenza A/B Test Receives EUA
The test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B.
Read MorePosted by Laurie Bonner | Sep 4, 2020 | Covid 19, Hematology & Serology |
The test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B.
Read MorePosted by Melanie Hamilton-Basich | Sep 2, 2020 | Covid 19, Rapid Assays |
Roche will launch a covid-19 Rapid Antigen Test in late September for markets accepting the CE Mark.
Read MorePosted by Laurie Bonner | Sep 2, 2020 | Cancer |
The resource serves as set of generic analytical protocols and helps to define industry standards in the development of liquid biopsy tests.
Read MorePosted by Melanie Hamilton-Basich | Aug 29, 2020 | Cancer, Molecular Diagnostics |
Foundation Medicine’s FoundationOne Liquid CDx is a pan-tumor liquid biopsy test for patients with solid tumors.
Read MorePosted by Laurie Bonner | Aug 28, 2020 | Company News, Covid 19 |
The $760 million agreement is for 150 million rapid coronavirus tests called BinaxNOW made by Abbott Laboratories.
Read More